Trial NCT01287741

View at ClinicalTrials.gov 
Org. Study IDs: BO21005
Secondary IDs: 2010-024194-39

Last trial update was posted on 2019-04-12

MeSH Interventions

Cyclophosphamide Doxorubicin Obinutuzumab Prednisone Rituximab Vincristine

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Other Conditions

Diffuse Large B-Cell Lymphoma

Stopping Reasons

The study was closed by the Sponsor according to the protocol-specified minimum post-treatment follow-up period of 3 years.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID